Farallon Capital Management’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
Other funds holding ASND
Farallon Capital Management's ASND Position: Q1 2026 in Review
Farallon Capital Management sold out of Ascendis Pharma (ASND) in Q1 2026, closing a stake of 1,400 shares — an estimated $299K sold.
Farallon Capital Management first reported a position in ASND in Q1 2018 and held it in 20 quarters. The position peaked at $193M in Q3 2020. 277 funds tracked by Wall St. Rank hold ASND as of Q1 2026.
- Farallon Capital Management reported no remaining Ascendis Pharma position as of Q1 2026 after selling out during the quarter.
- Farallon Capital Management sold 1,400 Ascendis Pharma shares in Q1 2026, an estimated $299K.
- Farallon Capital Management first reported a position in Ascendis Pharma in Q1 2018 and held it in 20 quarters.
- Farallon Capital Management's Ascendis Pharma position peaked at $193M in Q3 2020.
- 277 funds tracked by Wall St. Rank held Ascendis Pharma as of Q1 2026.
Based on Farallon Capital Management's 13F filing for Q1 2026, filed 15 May 2026.